CC
Casdin Capital Portfolio holdings
AUM
$1.1B
1-Year Return
24.98%
This Quarter Return
+10.64%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
–
AUM
$3.94B
AUM Growth
+$582M
(+17%)
Cap. Flow
+$513M
Cap. Flow
% of AUM
13.02%
Top 10 Holdings %
Top 10 Hldgs %
57.23%
Holding
59
New
11
Increased
8
Reduced
3
Closed
5
Top Buys
| 1 |
VERV
Verve Therapeutics
VERV
|
+$183M |
| 2 |
Century Therapeutics
IPSC
|
+$94.1M |
| 3 |
OMIC
Singular Genomics Systems, Inc. Common Stock
OMIC
|
+$74M |
| 4 |
AMRS
Amyris Inc.
AMRS
|
+$49.1M |
| 5 |
ME
23andMe Holding Co. Class A Common Stock
ME
|
+$32M |
Top Sells
| 1 |
BNR
Burning Rock Biotech
BNR
|
+$22.8M |
| 2 |
Adverum Biotechnologies
ADVM
|
+$21.8M |
| 3 |
Taysha Gene Therapies
TSHA
|
+$16.7M |
| 4 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
+$15.5M |
| 5 |
Dyne Therapeutics
DYN
|
+$9.47M |
Sector Composition
| 1 | Healthcare | 88.3% |
| 2 | Materials | 1.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Stoke Therapeutics
STOK
$1.29B
| $4.04M | 0.1% |
120,000
| – | – |
|
52
Foghorn Therapeutics
FHTX
$293M
| $2.31M | 0.06% |
216,216
| – | – |
|
|
ZY
53
DELISTED
Zymergen Inc. Common Stock
ZY
| $1.2M | 0.03% |
+30,000
| New | +$1.2M |
|
54
Sana Biotechnology
SANA
$828M
| $1.18M | 0.03% |
60,000
| – | – |
|
|
55
Adverum Biotechnologies
ADVM
$63.4M
| – | – |
-221,162
| Closed | -$21.8M |
|
|
BNR
56
Burning Rock Biotech
BNR
$89.4M
| – | – |
-84,715
| Closed | -$22.8M |
|
|
57
Dyne Therapeutics
DYN
$1.87B
| – | – |
-610,000
| Closed | -$9.47M |
|
|
58
Taysha Gene Therapies
TSHA
$837M
| – | – |
-820,440
| Closed | -$16.7M |
|
|
CDAK
59
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| – | – |
-76,688
| Closed | -$1.16M |
|